Syndax Pharmaceuticals, Inc. (SNDX) P/E Ratio, ROE & Key Statistics
$8.56NASDAQ: SNDXMarket Cap $770.64M
Data as of Nov 18, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Syndax Pharmaceuticals, Inc. (SNDX), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-3.85
P/B ratioShare price divided by book value per share.
-47.72
P/S ratioMarket value divided by annual revenue.
2.84
PEG ratioP/E divided by the earnings growth rate.
-0.09
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-10.69
EV / RevenueEnterprise value against annual revenue.
4.41
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-14.33%
Free cash flow yieldFree cash flow as a percentage of market value.
-21.59%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
93.69%
Operating marginRevenue left after operating costs.
-61.72%
Net marginRevenue left after every cost, including tax and interest.
-72.38%
Return on equityProfit as a percentage of shareholders’ equity.
-804.38%
Return on assetsProfit as a percentage of total assets.
-30.24%
Return on capital employedOperating profit against the capital the business uses.
-31.25%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
4.69
Quick ratioThe same, excluding inventory.
4.37
Cash ratioCash alone against current liabilities.
1.13
Debt to equityTotal borrowings against shareholders’ equity.
-34.31
Debt to assetsTotal borrowings against total assets.
0.65
Interest coverageHow many times operating profit covers the interest bill.
-1.98
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$3.29
Market capitalisationShare price times shares outstanding.
$770.64M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$859.96M
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Syndax Pharmaceuticals, Inc. (SNDX) statistics — frequently asked questions
What is Syndax Pharmaceuticals, Inc.'s P/E ratio?
Syndax Pharmaceuticals, Inc. (SNDX) trades on a price-to-earnings ratio of -3.85. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Syndax Pharmaceuticals, Inc.'s return on equity?
Syndax Pharmaceuticals, Inc. (SNDX) reports a return on equity of -804.38%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Syndax Pharmaceuticals, Inc. carry?
Syndax Pharmaceuticals, Inc. (SNDX) has a debt-to-equity ratio of -34.31, which compares total borrowings with shareholders' equity.
What is Syndax Pharmaceuticals, Inc.'s profit margin?
Syndax Pharmaceuticals, Inc. (SNDX) keeps -72.38% of revenue as net profit after every cost, including tax and interest.